openPR Logo
Press release

A Deep Dive into Granulomatosis With Polyangiitis Treatment Market 2025: Key Drivers, Growth Factors, and Projections 2025-2034

03-25-2025 04:23 PM CET | Health & Medicine

Press release from: The Business Research Company

Granulomatosis With Polyangiitis Treatment

Granulomatosis With Polyangiitis Treatment

Which drivers are expected to have the greatest impact on the over the granulomatosis with polyangiitis treatment market's growth?
The growing prevalence of autoimmune diseases is expected to fuel the expansion of the granulomatosis with polyangiitis treatment market. Autoimmune diseases occur when the immune system mistakenly attacks healthy cells and tissues, leading to inflammation and organ damage. Factors like environmental triggers (e.g., infections, chemicals, or pollutants) and lifestyle changes are contributing to the rise in autoimmune diseases. Granulomatosis with polyangiitis treatment often involves immunosuppressive therapies such as corticosteroids and cyclophosphamide to control inflammation and prevent organ damage. Early intervention and tailored treatment are crucial for managing autoimmune diseases with similar mechanisms. For instance, a report by the Office for National Statistics in June 2023 showed the global population with multiple sclerosis (MS), an autoimmune disease, increased from 2.8 million in 2022 to 2.9 million in 2023. As the prevalence of autoimmune diseases continues to rise, the granulomatosis with polyangiitis treatment market will experience growth.

Get Your Granulomatosis With Polyangiitis Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/report/granulomatosis-with-polyangiitis-treatment-global-market-report

What is the future CAGR of the granulomatosis with polyangiitis treatment market, and how will it impact industry expansion?
The granulomatosis with polyangiitis treatment market has grown significantly, expanding from $2.36 billion in 2024 to $2.56 billion in 2025 at a CAGR of 8.2%. Growth has been fueled by rising demand for effective drugs, increasing numbers of clinical trials, higher emphasis on personalized medicine, and greater diagnosis rates of the disorder.

The granulomatosis with polyangiitis treatment market size is projected to experience significant growth in the coming years. It is expected to reach $3.47 billion by 2029, expanding at a compound annual growth rate (CAGR) of 7.9%. This growth during the forecast period is driven by the rising incidence of autoimmune diseases, an increasing prevalence of granulomatosis, a surge in polyangiitis cases, and a growing occurrence of immunological disorders. Key trends expected include advancements in drug development, progress in healthcare infrastructure, improvements in diagnostic methods, innovations in treatment approaches, and the emergence of biologics and biosimilars.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21196&type=smp

What are the most significant trends transforming the granulomatosis with polyangiitis treatment market today?
Major companies operating in the granulomatosis with polyangiitis (GPA) treatment market are advancing therapies like oral corticosteroids to provide more effective treatment options while minimizing the long-term side effects typically associated with steroid use. Oral corticosteroids help reduce inflammation and suppress immune responses, making them a cornerstone of treatment for autoimmune diseases. In October 2024, AstraZeneca plc, a UK-based pharmaceutical company, announced that Fasenra (bevacizumab) was approved in the European Union as an add-on treatment for adult patients with relapsing or refractory eosinophilic granulomatosis with polyangiitis (EGPA). This approval was based on positive results from the MANDARA Phase III trial, which demonstrated that Fasenra could help patients achieve remission and reduce reliance on oral corticosteroids.

Which key market segments comprise the granulomatosis with polyangiitis treatment market and drive its revenue growth?
The granulomatosis with polyangiitis treatment market covered in this report is segmented -

1) By Drug Type: Steroids, Immunosuppressant, Other Drug Types
2) By Treatment Type: Immunosuppressants, Corticosteroids
3) By Route Of Administration: Oral, Intravenous
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:
1) By Steroids: Prednisone, Methylprednisolone, Dexamethasone, Hydrocortisone
2) By Immunosuppressants: Cyclophosphamide, Methotrexate, Azathioprine, Mycophenolate mofetil, Rituximab
3) By Other Drug Types: Plasma Exchange Therapy, Intravenous Immunoglobulin (IVIG), Biologic Agents, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21196

What regions are at the forefront of granulomatosis with polyangiitis treatment market expansion?
North America was the largest region in the granulomatosis with polyangiitis treatment market in 2024. The regions covered in the granulomatosis with polyangiitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the leading players fueling growth in the granulomatosis with polyangiitis treatment market?
Major companies operating in the granulomatosis with polyangiitis treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, GlaxoSmithKline plc, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Vertex Pharmaceuticals Incorporated, Genentech Inc., Incyte Corporation, Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., ChemoCentryx Inc., Medac Pharma Inc., InflaRx GmbH

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21196&type=smp

What Is Covered In The Granulomatosis With Polyangiitis Treatment Global Market Report?

•Market Size Forecast: Examine the granulomatosis with polyangiitis treatment market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the granulomatosis with polyangiitis treatment market for a structured understanding.
•Key Players Overview: Analyze major players in the granulomatosis with polyangiitis treatment market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the granulomatosis with polyangiitis treatment market.
•Segment Contributions: Evaluate how different segments drive overall growth in the granulomatosis with polyangiitis treatment market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the granulomatosis with polyangiitis treatment market.
•Industry Challenges: Identify potential risks and obstacles affecting the granulomatosis with polyangiitis treatment market.
•Competitive Landscape: Review strategic developments in the granulomatosis with polyangiitis treatment market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release A Deep Dive into Granulomatosis With Polyangiitis Treatment Market 2025: Key Drivers, Growth Factors, and Projections 2025-2034 here

News-ID: 3936928 • Views:

More Releases from The Business Research Company

Future of the Stone Flooring Market: Trends, Innovations, and Key Forecasts Through 2034
Future of the Stone Flooring Market: Trends, Innovations, and Key Forecasts Thro …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Stone Flooring Market Size Growth Forecast: What to Expect by 2025? In recent years, the stone flooring market has significantly expanded. Expected to grow from $17.35 billion in 2024 to $18.50 billion in 2025, it presents a compound annual growth rate (CAGR) of 6.7%. Factors such as the growth
Spaceport Construction Market Insights 2025-2034: Growth Forecast and Strategic Priorities
Spaceport Construction Market Insights 2025-2034: Growth Forecast and Strategic …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Spaceport Construction Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for constructing spaceports has seen expedited growth in recent times. It is projected to increase from $1.39 billion in 2024 to $1.57 billion in 2025, demonstrating a compound annual growth rate
Strategic Forecast for the Rocket Materials Recycling Industry: Market Outlook 2025-2034
Strategic Forecast for the Rocket Materials Recycling Industry: Market Outlook 2 …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Rocket Materials Recycling Market Size Growth Forecast: What to Expect by 2025? The market scale of rocket material recycling has expanded significantly in recent times. Anticipated to swell from $1.12 billion in 2024 to approximately $1.26 billion in 2025, this indicates a compound annual growth rate (CAGR) of 12.9%.
Comprehensive 2025 Space-Based Quantum Computing Market Overview: Trends, Forecasts, and Growth Drivers
Comprehensive 2025 Space-Based Quantum Computing Market Overview: Trends, Foreca …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Space-Based Quantum Computing Market Through 2025? The market size for quantum computing in space has experienced significant expansions of late. Forecasts suggest a rise from $1.07 billion in 2024 to $1.29 billion in 2025, representing a compound annual growth rate (CAGR) of

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the